Skip to main content

Headlines

AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
MediWound Partners 3M For Phase III Study Of EscharEx For Leg Ulcer Treatment
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Genentech's Vabysmo Maintains Vision Improvements In Phase III Trials - Quick Facts
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Longeveron: Phase 2a Trial Validate Safety, Therapeutic Potential Of Lomecel-B In Mild Alzheimer's
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Freeline Reports Positive Data From First Cohort Of Phase 1/2 GALILEO-1 Trial Of FLT201
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Tesla Bull Shrugs Off Current Phase As 'Pause Into Next Phase Of Growth Story,' Calls UAW Strike A 'Win-Win' For EV Maker
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Novartis Announces Positive Results From Phase III Study Of Iptacopan In IgA Nephropathy
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Ascletis Announces Positive Interim Data From Phase IIb Expansion Cohort Of ASC22 For CHB
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
UNITY Biotechnology Reports Encouraging Results From Phase 2 ENVISION Study Of UBX1325
posted:
by: Nasdaq AAPL Apple
#channels:: #All, #Business, #Nasdaq, #Technology, #Stocks, #AAPL, #Apple
Ionis Reports Positive Results From Phase 3 Study Of Olezarsen In Familial Chylomicronemia Syndrome
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Roivant Reports Positive Initial Phase 1 Data For IMVT-1402
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Seelos Therapeutics: SLS-002 Phase II Study Fails To Meet Primary Endpoint On Limited Sample Size
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META